11 Amendments of Esther DE LANGE related to 2010/2153(INI)
Amendment 7 #
Motion for a resolution
Recital A
Recital A
Amendment 9 #
Motion for a resolution
Recital A
Recital A
A. whereas the national and international health authorities, including the WHO, were aware as early asstated in May 2009 that the H1N1 influenza was not virulent, wiat the this moderate virulence beime causing confirmed by the very low mortality rate observed as a result of ly mild illness, but that it could only be hoped (thius influenza ‘pandemic’ in comparison with the officially recognised figures for seasonal influenzanot taken for granted) that this pattern would continue,
Amendment 14 #
Motion for a resolution
Recital B
Recital B
Amendment 22 #
Motion for a resolution
Recital B a (new)
Recital B a (new)
Ba. Considering the high degree of unforeseeability and severity of how the pandemic was going to unfold, always with the possibility that the pandemic might worsen in Europe, as it did in 1918 and 1968;
Amendment 24 #
Motion for a resolution
Recital B c (new)
Recital B c (new)
Bc. Considering that under the principle of subsidiarity, the preparation and the reaction towards the health risks in the European Union fall within the competence of the Member States; that the treaty of Lisbon exhorts the Member States to strengthen the co-operation, the division of information and good practices within the framework of the WHO and the existing structures of the EU; that the reinforcement of the measurements of coordination taken by the Commission and the Member States, with the support of the ECDC and the EMEA within the framework of WHO, reinforces the effectiveness of the national measures.
Amendment 56 #
Motion for a resolution
Recital G
Recital G
Amendment 74 #
Motion for a resolution
Subheading 1
Subheading 1
Amendment 80 #
Motion for a resolution
Paragraph 1 a (new)
Paragraph 1 a (new)
1a. Emphasises the need to reinforce cooperation between Member States within the EU in the management of the response to a pandemic, within the framework of WHO, according to the International Health Regulation of 2005 ;
Amendment 85 #
Motion for a resolution
Paragraph 1 f (new)
Paragraph 1 f (new)
1f. Claims that work on the legal basis relating to the implementation of the joint buying guarantee to the Member States an equitable access and a reasonable price to the most effective vaccines as well as the respect of the European legislation in terms of the manufacturer responsibility;
Amendment 88 #
Motion for a resolution
Paragraph 1 i (new)
Paragraph 1 i (new)
1i. Welcomes the Commission's commitment to develop a mechanism for joint procurement of vaccines and antiviral medication which allows Member States, on a voluntary basis, a common acquisition of these products or common approaches to contract negotiations with the pharmaceutical industry; Recalls that only the seeking for joint solutions for a common purchasing of vaccines and antiviral medications will ensure equitable access, at the lowest price for the Member States;
Amendment 151 #
Motion for a resolution
Paragraph 10 b (new)
Paragraph 10 b (new)
10b. Requires a global European strategic approach for the so-called “at-risk” groups on how to reach them and communicate with them in case of pandemics;